Genesis of pandemic influenza

Cytogenetic and Genome Research

Volumn 117, Issue 1-4, 2007, Pages 394-402

  Sorrell, E M ^a   Ramirez Nieto, G C ^a,b   Gomez Osorio, I G ^a   Perez, D R ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

AVIAN INFLUENZA VACCINE; INFLUENZA VACCINE;

AVIAN INFLUENZA; DISEASE TRANSMISSION; HOST RANGE; HUMAN; INFLUENZA; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H7N7; INFLUENZA VIRUS A H9N2; NONHUMAN; PANDEMIC; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RNA SYNTHESIS; VACCINATION; VIRUS TRANSMISSION;

ANIMALS; BIRDS; DISEASE OUTBREAKS; HUMANS; IMMUNITY, NATURAL; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; INFLUENZA, HUMAN;

AVES; ORTHOMYXOVIRIDAE;

EID: 34547617178     PISSN: 14248581     EISSN: None     Source Type: Journal    
DOI: 10.1159/000103203     Document Type: Review

References (128)

1. Acland HM, Silverman Bachin LA, Eckroade RJ: Lesions in broiler and layer chickens in an outbreak of highly pathogenic avian influenza virus infection. Vet Pathol 21:564-569 (1984).
2. Alexander DJ: Ecological aspects of influenza A viruses in animals and their relationship to human influenza: a review. J R Soc Med 75:799-811 (1982).
3. Alexander DJ: A review of avian influenza in different bird species. Vet Microbiol 74:3-13 (2000).
4. Aragon T, de la Luna S, Novoa I, Carrasco L, Ortin J, Nieto A: Eukaryotic translation initiation factor 4GI is a cellular target for NS1 protein, a translational activator of influenza virus. Mol Cell Biol 20:6259-6268 (2000).
5. Banks J, Speidel ES, Moore E, Plowright L, Piccirillo A, et al: Changes in the haemagglutinin and the neuraminidase genes prior to the emergence of highly pathogenic H7N1 avian influenza viruses in Italy. Arch Virol 146:963-973 (2001).
6. Bazzigher L, Schwarz A, Staeheli P: No enhanced influenza virus resistance of murine and avian cells expressing cloned duck Mx protein. Virology 195:100-112 (1993).
7. Beare AS, Webster RG: Replication of avian influenza viruses in humans. Arch Virol 119:37-42 (1991).
8. Beaton AR, Krug RM: Transcription antitermination during influenza viral template RNA synthesis requires the nucleocapsid protein and the absence of a 5́capped end. Proc Natl Acad Sci USA 83:6282-6286 (1986).
9. Bernasconi D, Schultz U, Staeheli P: The interferon-induced Mx protein of chickens lacks antiviral activity. J Interferon Cytokine Res 15:47-53 (1995).
10. Bulaga LL, Garber L, Senne DA, Myers TJ, Good R, et al: Epidemiologic and surveillance studies on avian influenza in live-bird markets in New York and New Jersey, 2001. Avian Dis 47:996-1001 (2003).
11. Burgui I, Aragon T, Ortin J, Nieto A: PABP1 and eIF4GI associate with influenza virus NS1 protein in viral mRNA translation initiation complexes. J Gen Virol 84:3263-3274 (2003).
12. Burt DW: Applications of biotechnology in the poultry industry. Worlds Poult Sci J 58:5-13 (2002).
13. Burt DW: Chicken genome: current status and future opportunities. Genome Res 15:1692-1698 (2005).
14. Campbell CH, Webster RG, Breese SS Jr: Fowl plague virus from man. J Infect Dis 122:513-516 (1970).
15. Capua I, Marangon S: Vaccination policy applied for the control of avian influenza in Italy. Dev Biol (Basel) 114:213-219 (2003).
16. Capua I, Marangon S: Vaccination for avian influenza in Asia. Vaccine 22:4137-4138 (2004).
17. Capua I, Marangon S, Bonfanti L: Eradication of low pathogenicity avian influenza of the H7N3 subtype from Italy. Vet Rec 154:639-640 (2004).
18. Crawford PC, Dubovi EJ, Castleman WL, Stephenson I, Gibbs EP, et al: Transmission of equine influenza virus to dogs. Science 310:482-485 (2005).
19. Ellis TM, Bousfield RB, Bissett LA, Dyrting KC, Luk GS, et al: Investigation of outbreaks of highly pathogenic H5N1 avian influenza in waterfowl and wild birds in Hong Kong in late 2002. Avian Pathol 33:492-505 (2004).
20. Falcon AM, Fortes P, Marion RM, Beloso A, Ortin J: Interaction of influenza virus NS1 protein and the human homologue of Staufen in vivo and in vitro. Nucleic Acids Res 27:2241-2247 (1999).
21. Fouchier RA, Schneeberger PM, Rozendaal FW, Broekman JM, Kemink SA, et al: Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci USA 101:1356-1361 (2004).
22. Fouchier RA, Munster V, Wallensten A, Bestebroer TM, Herfst S, et al: Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 79:2814-2822 (2005).
23. Gambaryan A, Webster R, Matrosovich M: Differences between influenza virus receptors on target cells of duck and chicken. Arch Virol 147:1197-1208 (2002).
24. Gilbert M, Chaitaweesub P, Parakamawongsa T, Premashthira S, Tiensin T, et al: Free-grazing ducks and highly pathogenic avian influenza, Thailand. Emerg Infect Dis 12:227-234 (2006).
25. Gross G, Ikenberg H, Roussaki A, Drees N, Schopf E: Systemic treatment of condylomata acuminata with recombinant interferon-alpha-2a: low-dose superior to the high-dose regimen. Chemotherapy 32:537-541 (1986).
26. Guo Y, Xu X, Wan X: (Genetic characterization of an avian influenza A (H5N1) virus isolated from a sick goose in China). Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 12:322-325 (1998).
27. Haller O: Human MxA protein protects transgenic mice from infection with Thogoto virus. J Interferon Res 13:S121 (1993).
28. Hatada E, Fukuda R: Binding of influenza A virus NS1 protein to dsRNA in vitro. J Gen Virol 73:3325-3329 (1992).
29. Hatada E, Saito S, Fukuda R: Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells. J Virol 73:2425-2433 (1999).
30. Hatta M, Kawaoka Y: The continued pandemic threat posed by avian influenza viruses in Hong Kong. Trends Microbiol 10:340-344 (2002).
31. Helenius A: Unpacking the incoming influenza virus. Cell 69:577-578 (1992).
32. Hinshaw VS, Bean WJ, Webster RG, Sriram G: Genetic reassortment of influenza A viruses in the intestinal tract of ducks. Virology 102:412-419 (1980a).
33. Hinshaw VS, Webster RG, Bean WJ, Sriram G: The ecology of influenza viruses in ducks and analysis of influenza viruses with monoclonal antibodies. Comp Immunol Microbiol Infect Dis 3:155-164 (1980b).
34. Holsinger LJ, Nichani D, Pinto LH, Lamb RA: Influenza A virus M2 ion channel protein: a structure-function analysis. J Virol 68:1551-1563 (1994).
35. Horimoto T, Kawaoka Y: Reverse genetics provides direct evidence for a correlation of hemagglutinin cleavability and virulence of an avian influenza A virus. J Virol 68:3120-3128 (1994).
36. Horimoto T, Kawaoka Y: Biologic effects of introducing additional basic amino acid residues into the hemagglutinin cleavage site of a virulent avian influenza virus. Virus Res 50:35-40 (1997).
37. Horisberger MA: Interferon-induced human protein MxA is a GTPase which binds transiently to cellular proteins. J Virol 66:4705-4709 (1992).
38. Horisberger MA: Interferons Mx genes and resistance to influenza virus. Am J Respir Crit Care Med 152:S67-S71 (1995).
39. Huang TS, Palese P, Krystal M: Determination of influenza virus proteins required for genome replication. J Virol 64:5669-5673 (1990).
40. Hulse-Post DJ, Sturm-Ramirez KM, Humberd J, Seiler P, Govorkova E, et al: Role of domestic ducks in the propagation and biological evolution of highly pathogenic H5N1 influenza viruses in Asia. Proc Natl Acad Sci USA 102:10682-10687 (2005).
41. Humberd J, Guan Y, Webster RG: Comparison of the replication of influenza A viruses in Chinese ring-necked pheasants and chukar partridges. J Virol 80:2151-2161 (2006).
42. Ito T, Couceiro JN, Kelm S, Baum LG, Krauss S, et al: Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol 72:7367-7373 (1998).
43. Ito T, Goto H, Yamamoto E, Tanaka H, Takeuchi M, et al: Generation of a highly pathogenic avian influenza A virus from an avirulent field isolate by passaging in chickens. J Virol 75:4439-4443 (2001).
44. Kawaoka Y, Webster RG: Sequence requirements for cleavage activation of influenza virus hemagglutinin expressed in mammalian cells. Proc Natl Acad Sci USA 85:324-328 (1988).
45. Kawaoka Y, Naeve CW, Webster RG: Is virulence of H5N2 influenza viruses in chickens associated with loss of carbohydrate from the hemagglutinin? Virology 139:303-316 (1984).
46. Kawaoka Y, Nestorowicz A, Alexander DJ, Webster RG: Molecular analyses of the hemagglutinin genes of H5 influenza viruses: origin of a virulent turkey strain. Virology 158:218-227 (1987).
47. Kawaoka Y, Chambers TM, Sladen WL, Webster RG: Is the gene pool of influenza viruses in shore-birds and gulls different from that in wild ducks? Virology 163:247-250 (1988).
48. Kawaoka Y, Krauss S, Webster RG: Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J Virol 63:4603-4608 (1989).
49. Krug RM, Alonso-Caplen FV, Julkunen I, Katze MG: Expression and replication of the influenza virus genome, in Krug RM (ed): The Influenza Viruses, pp 89-152 (Plenum Press, New York 1989).
50. Krug RM, Yuan W, Noah DL, Latham AG: Intracellular warfare between human influenza viruses and human cells: the roles of the viral NS1 protein. Virology 309:181-189 (2003).
51. Kuiken T, Holmes EC, McCauley J, Rimmelzwaan GF, Williams CS, Grenfell BT: Host species barriers to influenza virus infections. Science 312:394-397 (2006).
52. Lamb RA: Genes and proteins of the influenza viruses, in Krug RM (ed): The Influenza Viruses (Plenum Press, New York 1989).
53. Lamb RA, Lai CJ: Sequence of interrupted and uninterrupted mRNAs and cloned DNA coding for the two overlapping nonstructural proteins of influenza virus. Cell 21:475-485 (1980).
54. Lamb RA, Lai CJ: Expression of unspliced NS1 mRNA spliced NS2 mRNA and a spliced chimera mRNA from cloned influenza virus NS DNA in an SV40 vector. Virology 135:139-147 (1984).
55. Lamb RA, Lai CJ, Choppin PW: Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins. Proc Natl Acad Sci USA 78:4170-4174 (1981).
56. Lee CW, Senne DA, Suarez DL: Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus. J Virol 78:8372-8381 (2004).
57. Lee SH, Vidal SM: Functional diversity of Mx proteins: variations on a theme of host resistance to infection. Genome Res 12:527-530 (2002).
58. Liu M, He S, Walker D, Zhou N, Perez DR, et al: The influenza virus gene pool in a poultry market in South central China. Virology 305:267-275 (2003).
59. Lu Y, Wambach M, Katze MG, Krug RM: Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology 214:222-228 (1995).
60. Makarova NV, Ozaki H, Kida H, Webster RG, Perez DR: Replication and transmission of influenza viruses in Japanese quail. Virology 310:8-15 (2003).
61. Marangon S, Capua I: Control of avian influenza in Italy: from stamping out to emergency and prophylactic vaccination. Dev Biol (Basel) 124:109-115 (2006).
62. Martin K, Helenius A: Transport of incoming influenza virus nucleocapsids into the nucleus. J Virol 65:232-244 (1991).
63. Martin V, Sims L, Lubroth J, Pfeiffer D, Slingenbergh J, Domenech J: Epidemiology and ecology of highly pathogenic avian influenza with particular emphasis on South East Asia. Dev Biol (Basel) 124:23-36 (2006).
64. Matrosovich M, Zhou N, Kawaoka Y, Webster R: The surface glycoproteins of H5 influenza viruses isolated from humans chickens and wild aquatic birds have distinguishable properties. J Virol 73:1146-1155 (1999).
65. Meier E, Kunz G, Haller O, Arnheiter H: Activity of rat Mx proteins against a rhabdovirus. J Virol 64:6263-6269 (1990).
66. Mullaney R: Live-bird market closure activities in the northeastern United States. Avian Dis 47:1096-1098 (2003).
67. Muller M, Brenig B, Winnacker EL, Brem G: Transgenic pigs carrying cDNA copies encoding the murine Mx1 protein which confers resistance to influenza virus infection. Gene 121:263-270 (1992).
68. Munster VJ, Wallensten A, Baas C, Rimmelzwaan GF, Schutten M, et al: Mallards and highly pathogenic avian influenza ancestral viruses, northern Europe. Emerg Infect Dis 11:1545-1551 (2005).
69. Nakayama M, Nagata K, Kato A, Ishihama A: Interferon-inducible mouse Mx1 protein that confers resistance to influenza virus is GTPase. J Biol Chem 266:21404-21408 (1991).
70. Nakayama M, Nagata K, Ishihama A: Enzymatic properties of the mouse Mx1 protein-associated GTPase. Virus Res 22:227-234 (1992).
71. Nemeroff ME, Qian XY, Krug RM: The influenza virus NS1 protein forms multimers in vitro and in vivo. Virology 212:422-428 (1995).
72. Nguyen DC, Uyeki TM, Jadhao S, Maines T, Shaw M, et al: Isolation and characterization of avian influenza viruses including highly pathogenic H5N1 from poultry in live bird markets in Hanoi, Vietnam in 2001. J Virol 79:4201-4212 (2005).
73. Notter DR: The importance of genetic diversity in livestock populations of the future. J Anim Sci 77:61-69 (1999).
74. Palese P, Ritchey MB, Schulman JL: Mapping of the influenza virus genome II. Identification of the P1, P2 and P3 genes. Virology 76:114-121 (1977).
75. Pavlovic J, Zurcher T, Haller O, Staeheli P: Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein. J Virol 64:3370-3375 (1990).
76. Peiris JS, Yu WC, Leung CW, Cheung CY, Ng WF, et al: Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 363:617-619 (2004).
77. Perez DR, Lim W, Seiler JP, Yi G, Peiris M, et al: Role of quail in the interspecies transmission of H9 influenza A viruses: molecular changes on HA that correspond to adaptation from ducks to chickens. J Virol 77:3148-3156 (2003a).
78. Perez DR, Webby RJ, Hoffmann E, Webster RG: Land-based birds as potential disseminators of avian mammalian reassortant influenza A viruses. Avian Dis 47:1114-1117 (2003b).
79. Perez DR, Sorrell EM, Donis RO: Avian influenza: an omnipresent pandemic threat. Pediatr Infect Dis J 24:S208-216, discussion S215 (2005).
80. Perkins LE, Swayne DE: Pathobiology of A/chicken/Hong Kong/220/97 (H5N1) avian influenza virus in seven gallinaceous species. Vet Pathol 38:149-164 (2001).
81. Perkins LE, Swayne DE: Pathogenicity of a Hong Kong-origin H5N1 highly pathogenic avian influenza virus for emus, geese, ducks and pigeons. Avian Dis 46:53-63 (2002a).
82. Perkins LE, Swayne DE: Susceptibility of laughing gulls (Larus atricilla) to H5N1 and H5N3 highly pathogenic avian influenza viruses. Avian Dis 46:877-885 (2002b).
83. Perkins LE, Swayne DE: Varied pathogenicity of a Hong Kong-origin H5N1 avian influenza virus in four passerine species and budgerigars. Vet Pathol 40:14-24 (2003).
84. Pinto LH, Holsinger LJ, Lamb RA: Influenza virus M2 protein has ion channel activity. Cell 69:517-528 (1992).
85. Pitossi F, Blank A, Schroder A, Schwarz A, Hussi P, et al: A functional GTP-binding motif is necessary for antiviral activity of Mx proteins. J Virol 67:6726-6732 (1993).
86. Plotch SJ, Bouloy M, Ulmanen I, Krug RM: A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription. Cell 23:847-858 (1981).
87. Qian XY, Chien CY, Lu Y, Montelione GT, Krug RM: An amino-terminal polypeptide fragment of the influenza virus NS1 protein possesses specific RNA-binding activity and largely helical backbone structure. RNA 1:948-956 (1995).
88. Reid AH, Fanning TG, Hultin JV, Taubenberger JK: Origin and evolution of the 1918 'Spanish' influenza virus hemagglutinin gene. Proc Natl Acad Sci USA 96:1651-1656 (1999).
89. Reid AH, Fanning TG, Janczewski TA, Taubenberger JK: Characterization of the 1918 'Spanish' influenza virus neuraminidase gene. Proc Natl Acad Sci USA 97:6785-6790 (2000).
90. Romanov MN: Poultry genetic resources in the countries of Eastern Europe - history and current state. Poult Avian Biol Rev 7:1-29 (1996).
91. Romanov MN, Weigend S: Analysis of genetic relationships between various populations of domestic and jungle fowl using microsatellite markers. Poult Sci 80:1057-1063 (2001).
92. Rott R, Klenk HD, Nagai Y, Tashiro M: Influenza viruses, cell enzymes and pathogenicity. Am J Respir Crit Care Med 152:S16-S19 (1995).
93. Samuel CE: Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology 183:1-11 (1991).
94. Schnorr JJ, Schneider-Schaulies S, Simon-Jodicke A, Pavlovic J, Horisberger MA, ter Meulen V: MxA-dependent inhibition of measles virus glycoprotein synthesis in a stably transfected human monocytic cell line. J Virol 67:4760-4768 (1993).
95. Scholtissek C: Source for influenza pandemics. Eur J Epidemiol 10:455-458 (1994).
96. Scholtissek C: Molecular evolution of influenza viruses. Virus Genes 11:209-215 (1995).
97. Scholtissek C: Molecular epidemiology of influenza. Arch Virol Suppl 13:99-103 (1997).
98. Scholtissek C, Rohde W, Von Hoyningen V, Rott R: On the origin of the human influenza virus subtypes H2N2 and H3N2. Virology 87:13-20 (1978).
99. Senne DA, Suarez DL, Stallnecht DE, Pedersen JC, Panigrahy B: Ecology and epidemiology of avian influenza in North and South America. Dev Biol (Basel) 124:37-44 (2006).
100. Shortridge KF: Pandemic influenza: a zoonosis? Semin Respir Infect 7:11-25 (1992).
101. Skehel JJ, Wiley DC: Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69:531-569 (2000).
102. Slemons RD, Condobery PK, Swayne DE: Assessing pathogenicity potential of waterfowl-origin type A influenza viruses in chickens. Avian Dis 35:210-215 (1991).
103. Staeheli P: Interferon-induced proteins and the antiviral state. Adv Virus Res 38:147-200 (1990).
104. Staeheli P, Haller O, Boll W, Lindenmann J, Weissmann C: Mx protein: constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus. Cell 44:147-158 (1986).
105. Stallknecht DE, Shane SM: Host range of avian influenza virus in free-living birds. Vet Res Commun 12:125-141 (1988).
106. Steinhauer DA: Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology 258:1-20 (1999).
107. Suarez DL, Schultz-Cherry S: Immunology of avian influenza virus: a review. Dev Comp Immunol 24:269-283 (2000).
108. Swayne DE, Halvorson DA: Influenza, in Saif YM (ed): Diseases of Poultry, pp 135-160 (Iowa State Press, Blackwell Publishing Co, Ames 2003).
109. Swayne DE, Suarez DL: Highly pathogenic avian influenza. Rev Sci Tech 19:463-482 (2000).
110. Tan SL, Katze MG: Biochemical and genetic evidence for complex formation between the influenza A virus NS1 protein and the interferon-induced PKR protein kinase. J Interferon Cytokine Res 18:757-766 (1998).
111. Taubenberger JK, Reid AH, Krafft AE, Bijwaard KE, Fanning TG: Initial genetic characterization of the 1918 'Spanish' influenza virus. Science 275:1793-1796 (1997).
112. Tompkins SM, Lo CY, Tumpey TM, Epstein SL: Protection against lethal influenza virus challenge by RNA interference in vivo. Proc Natl Acad Sci USA 101:8682-8686 (2004).
113. Tumpey TM, Suarez DL, Perkins LE, Senne DA, Lee JG, et al: Characterization of a highly pathogenic H5N1 avian influenza A virus isolated from duck meat. J Virol 76:6344-6355 (2002).
114. Tweed SA, Skowronski DM, David ST, Larder A, Petric M, et al: Human illness from avian influenza H7N3 British Columbia. Emerg Infect Dis 10:2196-2199 (2004).
115. Ulmanen I, Broni B, Krug RM: Influenza virus temperature-sensitive cap (m7GpppNm)-dependent endonuclease. J Virol 45:27-35 (1983).
116. Veits J, Wiesner D, Fuchs W, Hoffmann B, Granzow H, et al: Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza. Proc Natl Acad Sci USA 103:8197-8202 (2006).
117. von Grotthuss M, Rychlewski L: Influenza mutation from equine to canine. Science 311:1241-1242; author reply 1241-1242 (2006).
118. Walker JA, Kawaoka Y: Importance of conserved amino acids at the cleavage site of the haemagglutinin of a virulent avian influenza A virus. J Gen Virol 74:311-314 (1993).
119. Wan H, Perez DR: Quail carry sialic acid receptors compatible with binding of avian and human influenza viruses. Virology 346:278-286 (2006).
120. Webster RG: Influenza virus: transmission between species and relevance to emergence of the next human pandemic. Arch Virol Suppl 13:105-113 (1997).
121. Webster R, Hulse D: Controlling avian flu at the source. Nature 435:415-416 (2005).
122. Webster RG, Yakhno M, Hinshaw VS, Bean WJ, Murti KG: Intestinal influenza: replication and characterization of influenza viruses in ducks. Virology 84:268-278 (1978).
123. Webster RG, Bean W, Gorman OT, Chambers TM, Kawaoka Y: Evolution and ecology of influenza A viruses. Microbiol Rev 56:152-179 (1992).
124. Webster RG, Guan Y, Peiris M, Walker D, Krauss S, et al: Characterization of H5N1 influenza viruses that continue to circulate in geese in southeastern China. J Virol 76:118-126 (2002).
125. Wolff T, O'Neill RE, Palese P: Interaction cloning of NS1-I, a human protein that binds to the nonstructural NS1 proteins of influenza A and B viruses. J Virol 70:5363-5372 (1996).
126. Wolff T, O'Neill RE, Palese P: NS1-Binding protein (NS1-BP): a novel human protein that interacts with the influenza A virus nonstructural NS1 protein is relocalized in the nuclei of infected cells. J Virol 72: 7170-7180 (1998).
127. Wood JM, Major D, Newman RW, Dunleavy U, Nicolson C, et al: Preparation of vaccines against H5N1 influenza. Vaccine 20(suppl 2):S84-S87 (2002).
128. Yoon KJ, Cooper VL, Schwartz KJ, Harmon KM, Kim WI, et al: Influenza virus infection in racing greyhounds. Emerg Infect Dis 11:1974-1976 (2005).